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ABSTRACT Amyloid diseases are traditionally characterized by the appearance of inter- and intracellular ﬁbrillar protein
deposits, termed amyloid. Historically, these deposits have been thought to be the etiology of the disease. However, recent
evidence suggests that small oligomers of the amyloidogenic protein/peptide are the origin of neurotoxicity. Although the impor-
tance of identifying the toxic oligomeric species is widely recognized, such identiﬁcation is challenging because these oligomers
are metastable, occur at low concentration, and are characterized by a high degree of heterogeneity. In this work, a ﬂuorescently
labeled b-amyloid(1–40) is used as a model amyloidogenic peptide to test the effectiveness of what we believe is a novel
approach based on single-molecule spectroscopy. We ﬁnd that by directly counting the photobleaching steps in the ﬂuores-
cence, we can determine the number of subunits in individual b-amyloid(1–40) oligomers, which allows us to easily distinguish
among different species in the mixtures. The results are further analyzed by comparison with Monte Carlo simulations to show
that the variability seen in the size of photobleaching steps can be explained by assuming random dipole orientations for the
chromophores in a given oligomer. In addition, by accounting for bias in the oligomer size distribution due to the need to subtract
background noise, we can make the results more quantitative. Although the oligomer size determined in this work is limited to
only small species, our single-molecule results are in good quantitative agreement with high-performance liquid chromatography
gel ﬁltration data and demonstrate that single-molecule spectroscopy can provide useful insights into the issues of heterogeneity
and ultimately cellular toxicity in the study of amyloid diseases.INTRODUCTION
Amyloid diseases, including neurodegenerative diseases
(e.g., Alzheimer’s and Parkinson’s), nonneuropathic sys-
temic diseases (e.g., AL amyloidosis), and nonneuropathic
localized diseases (e.g., type II diabetes), are generally
thought to be caused by amyloidogenic protein/peptide mis-
folding and aggregation (1–4). At least 34 different
proteins/peptides have been identified to date (4) that can
fold abnormally, form amyloid fibrils, and are associated
with pathology. However, the mechanism by which these
proteins/peptides gain their neurotoxic function upon mis-
folding and aggregation remains unclear. With evidence
from recent experiments, it has been suggested that the toxic
agents at the origin of amyloid diseases are oligomeric forms
of the amyloidogenic proteins/peptides (5–7), contrary to the
traditional view implicating fibrils. The toxic oligomeric form
may consist of only a few monomeric units. Indeed, atomic
force microscopy and scanning transmission electron micros-
copy studies have shown that small annular structures resem-
bling the pores formed by bacterial toxins are generated by
b-amyloid and a-synuclein (8–11).
Although identification of the toxic oligomer species has
become an important topic in studies of amyloid disease,
understanding the role of these species in toxicity has been
challenging. These amyloidogenic proteins/peptides usually
occur at extremely low physiological concentrations, often in
the nano- to subnanomolar range. Moreover, the amyloido-
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In some cases there is evidence that the structures of the
small oligomers are in dynamic equilibrium (12,13); hence,
ensemble studies mask the details of these features.
Here we present what to our knowledge is a new approach
for studying and identifying amyloidogenic oligomers based
on single-molecule fluorescence spectroscopy (SMS). For
our model system we use b-amyloid(1–40), a 40 amino
acid peptide that has been identified as the major component
of the extracellular plaques found in the brains of patients
with Alzheimer’s disease (14). Because of the high sensi-
tivity of confocal fluorescence microscopy, single oligomers
made of fluorescently labeled b-amyloid(1–40) peptide can
be readily identified and differentiated from other oligomers
containing a different number of subunits. We show that by
counting the number of photobleaching steps (15–17), one
can determine the number of monomers of each detected
b-amyloid(1–40) oligomer and thus resolve different equilib-
rium mixtures of b-amyloid while working at a protein
concentration below 1 nM. Monte Carlo simulations in
which b-amyloid oligomers are modeled as structures with
random dipole orientations of the fluorophore associated
with each monomer account for observed variations in
photobleaching trajectories, as well as for biasing due to
background noise subtraction, allowing us to improve the
quantitative interpretation of the data. In line with previous
work by Dukes et al. (17), who successfully applied SMS
to the study of early b-amyloid oligomers, in this study we
further investigated the single-molecule photobleaching
methodology by numerical simulations of orientation effects
doi: 10.1016/j.bpj.2009.05.035
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raphy (HPLC) data.
MATERIALS AND METHODS
b-Amyloid(1–40) preparation
HiLyte Fluor 488 b-amyloid(1–40) was obtained from AnaSpec (San Jose,
CA) and kept frozen at 20C. For the purpose of consistency, before any
samples were used, the peptide was first redissolved in trifluoroacetic acid
(Sigma-Aldrich, St. Louis, MO) at 1 mg/mL and then bath-sonicated for
at least 30 min to break apart any preformed aggregates (18). The solution
was then aliquoted into small samples, and finally lyophilized and stored
at 20C. To make a fresh b-amyloid(1–40) sample, the lyophilized powder
was directly dissolved in 10 mM sodium phosphate, 100 mM sodium chlo-
ride, pH 7.4 buffer, followed by a 60-s bath sonication.
Transmission electron microscopy
of ﬁbril formation
Both unlabeled b-amyloid(1–40) and HiLyte Fluor 488 b-amyloid(1–40)
were dissolved in 10 mM sodium phosphate, 100 mM sodium chloride,
pH 7.4 buffer in siliconized tubes (Corning, Corning, NY) to a final protein
concentration of 25 mM. After 6 days of incubation, small amounts of b-
amyloid(1–40) fibrils were pipetted onto grids and stained with uranyl
acetate. The samples were then imaged with a Philips CM12 transmission
electron microscope (New York, NY).
Gel ﬁltration HPLC
An aliquot of 20 mL of 5 mM fresh HiLyte Fluor 488 b-amyloid(1–40)
sample was run through a gel filtration column (TOSOH Bioscience, South
San Francisco, CA) at room temperature in 10 mM sodium phosphate,
100 mM sodium chloride, pH 7.4 buffer with a flow rate of 1 mL/min to
obtain fractions of different oligomer species. The molecular mass for this
column was calibrated by using the following proteins/molecules under
the same separation conditions: thyroglobulin (669 kDa), g-globulin (165
kDa), ovalbumin (43 kDa), RNase A (14 kDa), ubiquitin (8.6 kDa), apro-
tinin (6.5 kDa), and NATA (180 Da).
Confocal ﬂuorescence microscopy
The fluorescence photobleaching trajectories of single HiLyte Fluor 488
b-amyloid(1–40) oligomers were collected with a custom-made inverted
confocal scanning microscope (19,20) equipped with a 1.45 NA 60 oil-
immersion objective (Olympus, Center Valley, PA). The excitation laser
beam from an Arþ-ion laser (Melles-Griot, Carlsbad, CA) at 457.9 nm
was passed through a dichroic mirror and focused onto a cover glass (Fisher
Scientific, Pittsburgh, PA) coated with the sample at a laser power of 10 mW.
The sample fluorescence was collected by the same objective and then
passed through a 457.9 nm notch-plus filter (Kaiser, Ann Arbor, MI) and
a 520/60nm band-pass filter (Chroma, Rockingham, VT), and finally
detected by a single-photon-counting avalanche photodiode (Perkin-Elmer
Optoelectronics, Waltham, MA).
Sample preparation for single-molecule
photobleaching
For photobleaching experiments with the incubated HiLyte Fluor 488
b-amyloid(1–40) samples, the dissolved peptides were first diluted to
100 nM concentration. For the gel filtration chromatography-separated
HiLyte Fluor 488 b-amyloid(1–40) monomer/dimer fraction sample, the
peptide was used directly after fractionation. A further dilution of either
sample to a final concentration of 0.1–1 nM was applied before the HiLyteFluor 488 b-amyloid(1–40) oligomers were deposited onto a cover glass.
Two droplets of this diluted peptide solution were spin-coated onto the cover
glass at 2000 rpm until the cover glass became dry (~30–40 s at room
temperature). The cover glasses were precleaned by rinsing with Milli-Q
water and then baked in a kiln at ~500C for 2 h.
After the sample-coated cover glass was mounted under the microscope,
it was raster-scanned on a piezoelectric stage (Physik Instrumente, Auburn,
MA) until a preset count rate threshold indicating the presence of a fluorescent
oligomer was reached to initiate the recording of a photobleaching trajectory.
The photobleaching trajectories were recorded in time steps of 50 ms.
Photobleaching trajectory analysis
Both noise-filtering and photon-counting histogram (PCH) techniques were
used in the photobleaching trajectory analysis.
The forward-backward nonlinear digital filtering technique was initially
developed to extract small signals from ion channel recordings, and was later
introduced for application in the single-molecule field (21,22). The most
significant feature of this noise-filtering technique is that it can effectively
preserve fast transients in the signal. With minimum edge blurring, this
filtering technique is very suitable for our photobleaching trajectory analysis.
Note that the parameters of this digital filter need to be carefully chosen to
avoid signal distortions.
The PCH approach has been widely used in fluorescence correlation spec-
troscopy to differentiate multiple fluorescence intensity levels (23,24). This
technique has also been used in photobleaching experiments (15–17). The
number of photons detected per unit time from fluorophores (at excitation
levels below the saturation intensity) follows Poisson distributions. The
construction of a PCH can help reveal multiple fluorescence intensities by
showing the corresponding Poisson distributions.
As discussed further below, the combination of a noise-filtering technique
and a PCH allows for improved resolution of different fluorescence
intensities.
Simulation of photobleaching
A program to generate simulated stochastic photobleaching trajectories was
written in LabVIEW (National Instruments, Austin, TX) and involves the
following steps:
1. A random number generator is used to generate an integer (with a preset
upper limit) as the number of subunits in the oligomer.
2. A photobleaching time is assigned to each of the fluorophores in the
oligomer. These photobleaching times are randomly generated based
on the exponential probability distribution p ¼ ð1=tÞexpðt=tÞ, where
t is the preset photobleaching lifetime, reflecting the photostability of
the fluorophores that are maximally excited.
3. A fixed absorption dipole orientation angle q (relative to the cover glass
surface) is assigned to each of the fluorophores in the oligomer by
a random number generator.
4. A position g relative to the center of the laser beam focus is assigned to
the oligomer (we also assume that the intensity of the laser beam falls off
as a Gaussian profile expðg2=2Þ). This oligomer position is generated
randomly (with a preset upper limit) based on a uniform probability of
the oligomer being deposited on the cover glass.
5. According to the dipole orientation of each fluorophore and the position
of the oligomer, each fluorophore’s photobleaching time is adjusted
by ðcos2ðqÞexpðg2=2ÞÞ1, and the fluorescence intensity is adjusted
by cos2ðqÞcos2ðqþ wÞexpðg2=2Þ, where w is the angle between the
absorption dipole and the emission dipole. For simplicity, and with no
impact on the qualitative features of the simulation, we assume that
w¼ 0 since, although the relative angle between the absorption and emis-
sion dipoles of HiLyte Fluor 488 has not been determined, the strong
mirror image relationship between absorption and emission spectra indi-
cates that they reflect the same electronic transition.Biophysical Journal 97(3) 912–921
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added to yield a single photobleaching trajectory.
7. Poisson noise is added to the trajectory.
RESULTS
Comparison of ﬁbril formation between HiLyte
Fluor 488 labeled and unlabeled Ab(1–40)
It is critical to confirm that the fluorescence labeling of
b-amyloid(1–40) with HiLyte Fluor 488 does not alter its
aggregation and fibril formation. According to the three-
dimensional structure of b-amyloid(1–42) recently deter-
mined by NMR (25), the N-terminus where the fluorophore
resides has a rather flexible structure, which suggests that the
peptide’s aggregation should not be significantly altered by
the labeling.
Imaging of fibrils by transmission electron microscopy
(TEM) is a common and direct method for studying the fibril
formation of amyloidogenic proteins/peptides (26,27). We
used TEM to image the fibrils formed by both unlabeled
b-amyloid(1–40) and HiLyte Fluor 488-labeled b-amyloid
(1–40), and compared them side by side (Fig. 1). These
images confirm that HiLyte Fluor 488 b-amyloid(1–40) is
able to form fibrils, and both the timescale of the fibril forma-
tion and the morphology of the fibrils are similar to those of
the unlabeled b-amyloid(1–40).
We also obtained preliminary data on membrane permeabi-
lization byb-amyloid(1–40) (data not shown). Both unlabeled
b-amyloid(1–40) and HiLyte Fluor 488 b-amyloid(1–40)
caused membrane permeabilization on plane membranes.
This also confirms that the labeling of b-amyloid(1–40)
does not qualitatively alter the pore formation ability of the
peptide.
Gel ﬁltration HPLC of HiLyte Fluor 488 Ab(1–40)
oligomers
An aliquot of 20 mL of 5 mM freshly dissolved HiLyte Fluor
488 b-amyloid(1–40) in 10 mM sodium phosphate, 100 mM
sodium chloride, pH 7.4 buffer was run through a gel filtra-
tion column. The elution profile is shown in Fig. 2. ThreeBiophysical Journal 97(3) 912–921elution peaks centered at 11.3, 11.8, and 12.4 min are clearly
visible. According to the molecular mass calibration curve
for this column, these peaks correspond to molecular masses
of ~14.5 kDa, 9.6 kDa, and 5.9 kDa, respectively. A fourth,
minor peak elutes at 8.3 min, corresponding to a molecular
mass of ~150 kDa, representing a small amount of much
larger oligomeric species. The gel filtration chromatography
results clearly show that the b-amyloid(1–40) oligomers in
solution are heterogeneous.
Although the gel filtration chromatography clearly
demonstrates the presence of at least three elution peaks,
identification of the species based on the molecular mass
standards is not straightforward, for two main reasons: 1),
they do not correspond to the molecular masses of any
specific oligomers, bur rather fall between two oligomers;
and 2), the elution peaks are broader than those expected
for pure single species. We conclude that these peaks are
mixtures of two or more oligomeric species, as indicated
by the peak assignments in the figure. This may be due to
interaction between the oligomers and the column material,
as suggested by the asymmetric long tail on the elution
profile, or to some structural heterogeneity or some reequili-
bration among different b-amyloid(1–40) oligomer species
during the column separation. Hence, while the HPLC data
are instructive, it appears challenging to extract a molec-
ular-level understanding of the sizes of the different oligo-
mers of b-amyloid(1–40).
SMS determination of the size of ﬂuorescently
labeled Ab(1–40) oligomers
The fluorescence signals from single HiLyte Fluor 488
b-amyloid(1–40) oligomers were monitored by a single-
photon-counting avalanche photodiode with a nano- or sub-
nanomolar concentration of labeled peptide deposited on a
clean cover glass at a laser power of 10 mW. The number of
transitions between the fluorophore ground state and excited
singlet state is limited by photobleaching (typically less
than 107 transitions for organic dye molecules) causing the
fluorescence to disappear even though the excitation field
remains on. The underlying mechanism of photobleachingFIGURE 1 Comparison of unlabeled and HiLyte Fluor
488 labeled b-amyloid(1–40) fibril morphology. Both (A)
unlabeled and (B) labeled b-amyloid(1–40) were incubated
for 6 days and imaged with a transmission electron micro-
scope.
Single-Molecule b-Amyloid 915may vary, but it is assumed to proceed through the excited
triplet state, which is typically more reactive toward oxida-
tion, and lasts much longer than the excited singlet state.
Thus, the duration and intensity of fluorescence are controlled
by the laser power, the absorption cross section of the fluoro-
phore (a term that includes its orientation relative to the light’s
electric field), the fluorescence quantum yield, and the photo-
oxidation rate. In the experiments described here, HiLyte
Fluor 488 fluorophores typically photobleached within
a few seconds, occasionally extending to >30 s.
Fig. 3 shows a typical fluorescence confocal scanning
image of the cover glass surface coated with HiLyte Fluor
488-labeled b-amyloid oligomers, as well as a few typical
FIGURE 2 Elution profile of 5 mM HiLyte Fluor 488 b-amyloid(1–40)
from the HPLC gel filtration column (see text for details).photobleaching trajectories. Of all of the trajectories that
were collected, ~40% are ‘‘clean’’ trajectories (only shot
noise present) with recognizable photobleaching events
(for example, see Fig. 3, a and b, for trajectories of a dimer
and a hexamer). The remaining 60% contain significant
intensity fluctuations (much larger than shot noise) that
lack any resolvable photobleaching features (Fig. 3 c is an
example). This may be due to the fluorophores’ dipole move-
ment and/or interactions with the cover glass surface impuri-
ties, charges, etc. Although we determined that cleaning the
cover glass reduces the number of trajectories containing
these fluctuations, so far we have not been able to improve
the performance beyond the current ~40% ‘‘clean’’ trajecto-
ries. Since we could reliably use only the ‘‘clean’’ trajecto-
ries to determine the total number of photobleaching events
and extract the oligomer size, only these were considered in
our data analysis.
Determination of Ab(1–40) oligomer size
distributions
By using the photobleaching trajectories of a large number of
individual HiLyte Fluor 488 b-amyloid(1–40) oligomers, it
is possible to construct an oligomer size distribution by
making a histogram of the number of photobleaching eventsFIGURE 3 Typical fluorescence confocal scanning
image (40  40 pixels for 20  20 mm2) and three photo-
bleaching trajectories of HiLyte Fluor 488 Ab(1–40) oligo-
mers: (a) a dimer, (b) a hexamer, and (c) an example of
a trajectory with fluctuations that make it difficult to deter-
mine the number of photobleaching steps. These trajectories
are removed from the data set.
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in each photobleached oligomer. The determination of pho-
tobleaching events in a given trajectory involves both visual
inspection and signal processing, including noise reduction
and PCH (for more details see the Discussion section).
To demonstrate our ability to differentiate different olig-
omer distributions using the SMS approach, we used a
sample of unresolved HiLyte Fluor 488 b-amyloid(1–40)
and a sample of the monomer/dimer fraction collected
from the HPLC gel filtration (indicated in Fig. 4, inset).
The unresolved b-amyloid(1–40) sample is expected to be
a mixture of oligomers of different sizes, whereas the gel
filtration separated fraction is expected to contain only
monomers and dimers.
The histograms obtained for these two different samples
are compared in Fig. 4. This comparison clearly confirms
the higher degree of heterogeneity of the unresolved sample
compared to the gel filtration separated sample. More impor-
tantly, the histogram shows that the SMS approach can
distinguish between the two mixtures and that oligomers as
large as hexamers are found in the unchromatographed
mixture. The HPLC separation does not detect oligomers
larger than tetramers, possibly because interactions with
the column result in a breakup of the larger oligomers. As
we show below in the Discussion section, this comparison
can be made even more quantitative.
DISCUSSION
Despite the intensive efforts and substantial progress made in
amyloid disease studies in recent years, there remains a lack
of understanding of how these amyloidogenic proteins/
peptides cause cell death. Although recent studies point to
early peptide oligomers as the key players in cytotoxicity,
FIGURE 4 Oligomer size distribution comparison between an unresolved
b-amyloid(1–40) sample and a gel filtration chromatography separated
monomer/dimer sample (the inset presents the same data shown in Fig. 2,
shown here for convenience). The monomer/dimer fraction was deposited
onto a cover glass immediately after it was collected from the column.
The SMS approach revealed significant contributions from larger oligomers
compared to those separated by HPLC. Further analysis below shows
improved quantitative analysis for the SMS data.Biophysical Journal 97(3) 912–921it has also been found that these oligomers are highly hetero-
geneous and exist in solution in a state of dynamic equilib-
rium (27–30). This makes it extremely challenging to apply
traditional approaches to determine the toxic species and
characterize the cytotoxicity mechanism. Traditional tech-
niques, such as gel filtration chromatography, are powerful
analytical tools for general protein studies, but in studies
dealing with small quantities of heterogeneous and meta-
stable protein/peptide assemblies, they are not adequate for
quantitative interpretations.
The emerging field of SMS provides a new approach for
characterizing early amyloidogenic oligomers. This study
of HiLyte Fluor 488 b-amyloid(1–40) demonstrates that
with the use of confocal fluorescence microscopy, one can
identify single oligomers and determine their sizes. This
allows individual oligomers and thus pure species, instead
of an averaged ensemble, to be studied, thus enabling a
more direct and potentially quantitative characterization.
To determine HiLyte Fluor 488 b-amyloid(1–40) olig-
omer photobleaching events in the recorded trajectories,
we employ an analysis that includes visual inspection and
signal processing. However, a common feature observed in
all of the photobleaching trajectories is that bright fluoro-
phores typically photobleach much more rapidly than
dimmer ones. Based on this observation, we analyze our
data in the following way: For the ‘‘large digital drop’’-
type photobleaching events, which usually correspond to
bright fluorophores, visual inspection is adequate for count-
ing the number of photobleaching steps. In contrast, for pho-
tobleaching trajectories in which only a small fluorescence
change occurs (see Fig. 5, a and c), an analysis of noise
reduction followed by fluorescence PCH provides an
improved differentiation of two rather close fluorescence
intensity levels (see Fig. 5, b and d). In Fig. 5 c, the PCH
of the raw trajectory is well fitted with two Gaussian distri-
butions, indicating that there are two close fluorescence
intensity levels. After the forward-backward nonlinear filter
is applied to the raw trajectory, these two fluorescence inten-
sities are clearly separated on the PCH (Fig. 5 d). These close
fluorescence intensity levels, resolved by noise reduction and
PCH, usually correspond to dim fluorophores. Thanks to the
typically long duration of these weak fluorescence signals,
an adequate number of photons can still be collected to allow
us to resolve these dim fluorophore photobleaching events.
It is important to note that despite the sample preparation
and cover glass cleaning procedures employed, not all of the
trajectories could be analyzed reliably. By following the
above analysis, we were able to analyze ~40% of the trajec-
tories. The remaining 60% lack any distinct fluorescence
intensity levels that can be resolved either visually or by
the fluorescence PCH (see Fig. 3 c). These trajectories are
noisy, with continuous fluorescence variations that on
some occasions are even nonmonotonic. Thus, these were
removed from the data set. Dark states are also occasionally
observed in the photobleaching trajectories. These appear as
Single-Molecule b-Amyloid 917FIGURE 5 (a) Photobleaching trajectory showing two
close fluorescence intensity levels. (b) The same trajectory
after filtering by the forward-backward nonlinear filter. (c)
The PCH of the raw trajectory. The solid curves show that
this histogram is well fitted with two Gaussian distributions
(with widths being equal to the square root of their means).
(d) The PCH of the filtered trajectory. The two fluorescence
levels are now clearly separated after the noise reduction.photobleaching events, but recover (usually to the original
fluorescence intensity level) after some time. The reason
for this behavior is not clear, but it could be due to electron
traps within the fluorophore local environment or to slow
changes in the fluorophore dipole orientation, since the
b-amyloid(1–40) oligomers were nonspecifically adsorbed
onto the cover glass surface. Agarose gel was also tested
as a matrix for immobilizing b-amyloid(1–40) oligomers
for single-molecule experiments. However, the large
‘‘pore’’ size in agarose gel makes it very difficult to trap
peptide monomers, and the high viscosity also makes an
even distribution of oligomers in the agarose gel very
unlikely. Alternative sample preparation methodologies, as
well as modifications to the microscope, to minimize these
complications remain under investigation.
In the analysis of the above trajectories, the relative fluores-
cence intensity was not used as a measure of the number of
monomeric units, because it is not a faithful reporter of olig-
omer size. There are three main reasons for this: First, it is
likely that different fluorophores, even in the same oligomer,
will adopt different orientations for both the absorption and
emission dipoles, thus yielding different fluorescence intensi-
ties. Second, even for fluorophores with the same dipole
orientation, the fluorescence intensities may differ due to
different interactions with surface impurities, charges, etc.
Third, the excitation intensity of a fluorophore depends on
where the oligomer is placed relative to the focus of the laser
beam, which generally has a Gaussian intensity profile,
producing different fluorescence intensities. Hence, there isno direct correlation between the observed fluorescence inten-
sity and the oligomer size. Other sample immobilization tech-
niques could make the use of intensity less sensitive to these
issues.
Further inspection of the analyzed trajectories indicates
that they can be characterized by two features: 1), the photo-
bleaching steps in fluorescence intensity in a given oligomer
are not equal; and 2), the trajectories often have a large and
fast initial fluorescence drop, which is often followed by a
long and low fluorescence tail before photobleaching occurs
(see Fig. 6, a and b, for examples). To understand these
features better, we considered a simple dipole orientation
model. The model was tested with the use of a stochastic
simulation program.
Considering that our sample was spin-coated onto a cover
glass, and the b-amyloid(1–40) oligomers were trapped on
the glass surface by nonspecific interactions, it is reasonable
to assume that the fluorophores, which are attached to the
oligomers, do not adopt the same dipole orientation. The
fact that the noise in these analyzable trajectories is nearly
shot noise-limited indicates that these photobleached fluoro-
phores have relatively fixed dipole orientations. The above
two considerations suggest that fluorophores with a less
favorably oriented transition dipole would be excited less
frequently, emit fewer photons per unit time, and hence pho-
tobleach more slowly (since the excitation rate is lower).
To test this hypothesis, we simulated the photobleaching
trajectory of an oligomer assuming that its individual fluoro-
phores have random but fixed dipole orientations, and theBiophysical Journal 97(3) 912–921
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with a large and fast initial drop. (b) Experimental photo-
bleaching trajectory with a long, low tail. (c) Simulated
photobleaching trajectory with a large, fast initial drop.
(d) Simulated photobleaching trajectory with a long, low
tail (photobleaching events are highlighted by the circles
and arrows).excitation field is circularly polarized. Based on this model,
it is anticipated that with a more parallel orientation of the
fluorophore dipole relative to the cover glass surface, the
fluorophore will be more frequently excited and the fluores-
cence intensity will be higher, and thus the time required for
photobleaching will be shorter. Note: In the plane parallel to
the cover glass, the laser was circularly polarized, so there
was no dependence of the excitation on the absorption dipole
angle projected onto the cover glass plane.
Using the stochastic simulation described above in Mate-
rials and Methods, and the random dipole orientation model,
we produced photobleaching trajectories. Typical trajecto-
ries are shown in Fig. 6, c and d, and clearly resemble the
experimental trajectories in Fig. 6, a and b, which represent
a monomer and a trimer, respectively. Although such a simu-
lation does not prove that the proposed model is the origin of
the variability in the trajectories, it supports the notion that
different dipole orientations are a major contributor to the
variations in the photobleaching trajectories. In fact, we
observed the same variability in fluorescence intensities
and photobleaching behavior in the fluorophore-only control
experiments (data not shown) as in the fluorophore-labeled
b-amyloid experiments.
In addition to its likely important contribution to the vari-
ation in the photobleaching trajectories, the random dipole
orientation model also suggests some possible systematic
errors embedded in the data. For the photobleaching experi-
ments, a threshold is preset such that when the detected fluo-
rescence signal is higher than this threshold, the scanning is
paused and the recording of a photobleaching trajectory is
triggered. This helps to mitigate background fluorescenceBiophysical Journal 97(3) 912–921and prevent any unwanted triggering by the occasionally
very high local background noise from the cover glass.
However, thresholding may also bias the data set toward
brighter fluorophores and thus against monomers and, to a
lesser extent, other small oligomers.
To quantify the effect of thresholding, we performed
another stochastic simulation. In this simulation, we used
the same photobleaching trajectory generation program as
described in Materials and Methods. Based on the discussion
above, it is expected that, depending on the initial fluores-
cence intensities of these simulated trajectories, some will
be recorded whereas others will be missed because they are
below the preset threshold. Hence, for each oligomer species,
we let the program continuously generate photobleaching
trajectories until the number of the ‘‘observed’’ (above-
threshold) trajectories matched that in our experimental
single-molecule data. The total number of these generated
trajectories includes both ‘‘recorded’’ and ‘‘missed’’ oligo-
mers, and thus represents the corrected number for those
specific oligomeric species. Because of the stochastic nature
of this simulation, we repeated it 10,000 times for each olig-
omer species. Fig. 7 shows a comparison of the observed
oligomer distribution from Fig. 4 and the corrected distribu-
tion of the same data.
Not surprisingly, the effect of the correction decreases
with the increase in oligomer size, since the more fluoro-
phores an oligomer contains, the less likely it is to be missed
due to thresholding. The simulation results confirmed this. It
should also be noted that in this simulation, an empirical
value was used to estimate the maximum fluorescence emis-
sion rate from a single fluorophore under the microscope
Single-Molecule b-Amyloid 919(This corresponds to the fluorophores that are at the center of
the beam focus and whose dipole orientations are along the
excitation field). Different values for this maximum emission
rate yield slightly different corrected distributions, but the
overall shapes of the corrected oligomer distributions remain
similar.
Besides the threshold effect, there are other factors that
might cause systematic errors in the estimation of oligomer
size, such as self-quenching between fluorophores within
an oligomer, which could result in an underestimate of this
size. Also, the random dipole orientation assumption may
not represent the true distribution for real samples on cover
glass, and possible slow movements of the fluorophore
dipoles on the cover glass may complicate the data analysis
as well. In general, an immobilization of free rotating oligo-
mers in an aqueous environment is preferable; this is a focus
of ongoing work.
To test the validity of our procedure for correcting the
photobleaching-derived distribution, we performed a control
experiment on dye-labeled parvalbumin. The mass spectros-
copy data of this parvalbumin sample indicate 48.6% single-
labeling, 44.5% double-labeling, and 6.9% triple-labeling
mixtures. Fig. 8 shows the comparison of the corrected
SMS data with the mass spectroscopy data. (The smaller
error bars here compared to those in Fig. 7 are due to an
improved thresholding algorithm with a CCD camera used
in the control experiment. The real errors, however, should
be larger than those error bars because the uncertainties of
the empirical estimates used in the simulation are not indi-
cated in the figure.) It clearly demonstrates that our single-
molecule approach can accurately reconstruct the content
distribution of the studied sample.
We further analyzed our b-amyloid(1–40) sample by
comparing the single-molecule data with the HPLC gel filtra-
tion-derived oligomer distribution of the same sample. This
allowed us to gain more insight into this heterogeneous
and dynamic mixture. To correlate these two sets of data,
we applied a multiple Gaussian distribution fitting to the
gel filtration elution profile, as shown in Fig. 9 a. Depending
FIGURE 7 Comparison of the observed oligomer distribution and the
corrected oligomer distribution.on the choice of the fitting windows and the initial parame-
ters, this procedure yielded several different fits with only
slightly different peak heights, widths, and positions, and
FIGURE 8 Comparison of the mass-spectroscopy distribution with the
corrected single-molecule distribution in the parvalbumin control experi-
ment.
FIGURE 9 (a) Multiple Gaussian fitting was applied to the gel filtration
elution profile. The ‘‘experimental’’ curve indicates the raw data of the
elution profile, and the ‘‘fitted’’ curve indicates a typical good fitting result,
which is the summation of monomer, dimer, trimer, tetramer, and baseline.
These two curves closely match each other. (b) Comparison of the relative
oligomer size distributions derived from different data sets: the gel filtration
profile and the corrected single-molecule data. The data are normalized so
that they give the same ratio for the monomer.Biophysical Journal 97(3) 912–921
920 Ding et al.with nearly the same quality of fit. Fig. 9 a shows a typical fit
with four Gaussian peaks and a fifth, low and broad distribu-
tion describing the slowly varying background. According to
their elution times, these four peaks most probably represent
four different oligomer species: monomer, dimer, trimer, and
tetramer, respectively.
Integration of the area under each peak yields the total far-
ultraviolet absorption for each b-amyloid(1–40) oligomer
species. Assuming that the average absorptivity of the peptide
backbone does not change upon oligomerization (i.e., that the
average absorptivity of a dimer is twice that of a monomer), an
oligomer size distribution of b-amyloid(1–40) was derived
from the absorption of each species. This was done for each
of the best four fits to the HPLC elution profile, and an aver-
aged oligomer distribution was derived. A similar relative
distribution was constructed from the corrected single-mole-
cule data shown in Fig. 7. Fig. 9 b presents a comparison of
these two relative distributions obtained with our two
different methods.
The results show relatively good agreement in terms of
oligomer size distribution between the single-molecule
approach and the gel filtration chromatography approach.
This confirms that our sample preparation for single-molecule
detection did not distort the b-amyloid oligomer distribution.
The agreement also indicates that, under our experimental
conditions for gel filtration chromatography, the oligomer
distribution does not reequilibrate very rapidly, and thus
both approaches are able to quantitatively reconstruct the
oligomer size distribution. However, the single-molecule
approach has some other advantages. The single-molecule
approach works at nanomolar or lower sample concentra-
tions, which could be extremely beneficial for amyloidogenic
studies. The determination of oligomer size is more direct in
the single-molecule approach, whereas there is some ambi-
guity in determining the oligomer size in the gel filtration
method since the positions of the elution peaks do not
correspond to individual oligomers very well, and there is
a broad baseline peak indicating the existence of an interac-
tion between some labeled peptides and column material. In
addition, the single-molecule approach successfully detected
oligomers larger than tetramers, whereas the gel filtration
method missed them. This suggests that b-amyloid(1–40)
oligomers that are larger than a tetramer may not be stable
during gel filtration. These large oligomers may have
reequilibrated themselves into smaller species during the
separation, contributing to the baseline peak.
CONCLUSIONS
In this work, an approach based on SMS was used to study
the heterogeneity of HiLyte Fluor 488 b-amyloid(1–40) olig-
omers. A fluorescently labeled b-amyloid(1–40) oligomer
mixture was ‘‘frozen’’ at a given time point by depositing
it onto a cover glass. The surface-bound oligomers were
then photobleached, and the number of subunits in individualBiophysical Journal 97(3) 912–921oligomers was determined by counting the photobleaching
events. By constructing a histogram of the number of
subunits in all of the individual oligomers, we were able to
extract an oligomer size distribution that was then corrected
according to our computer simulations. As an indication of
heterogeneity, the oligomer size distribution reveals the
intrinsic properties of a given b-amyloid(1–40) oligomer
mixture at a given time point. In addition to the work
described above, the single-molecule approach can also be
used to extract dynamic information. Real-time monitoring
of oligomer formation is possible if the laser power is low-
ered and the observation time window extended. Hence,
SMS potentially could be used to reveal transient events
that might occur in such a dynamic and heterogeneous
mixture and might be masked by any ensemble-averaging
measurements.
For large oligomers (we have identified oligomers as large
as octamer by photobleaching), the photobleaching events in
the fluorescence trajectory may become more difficult to
distinguish, and in some cases self-quenching among the flu-
orophores may increase as well. However, since most of the
recent evidence points to small oligomers, such as the pore-
like annular structures that are probably made of hexamer
units, as the pathologically relevant species in Alzheimer’s
disease (8–11), the single-molecule approach appears very
promising for studies of these small oligomers. We anticipate
that the detailed information on the early oligomers of amyloi-
dogenic proteins/peptides gained through SMS will provide
a deeper understanding of amyloid diseases.
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